| 4501 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
56 |
| 4502 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
64 |
| 4503 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4504 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
73 |
| 4505 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4506 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
37 |
| 4507 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
59 |
| 4508 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
70 |
| 4509 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
74 |
| 4510 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
66 |
| 4511 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
22 |
| 4512 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
64 |
| 4513 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
70 |
| 4514 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
70 |
| 4515 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
67 |
| 4516 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
60 |
| 4517 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
68 |
| 4518 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
58 |
| 4519 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
67 |
| 4520 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
47 |
| 4521 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
56 |
| 4522 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
55 |
| 4523 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
64 |
| 4524 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
66 |
| 4525 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
65 |
| 4526 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4527 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
69 |
| 4528 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4529 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2020 |
Standard Therapy |
Germany |
73 |
| 4530 |
Apheresis |
Allogeneic |
Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4531 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2020 |
Standard Therapy |
Poland |
69 |
| 4532 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2020 |
Standard Therapy |
Poland |
70 |
| 4533 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4534 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2020 |
Standard Therapy |
Poland |
62 |
| 4535 |
Apheresis |
Allogeneic |
Myelofibrosis With Myeloid Metaplasia |
Hematology |
2020 |
Standard Therapy |
Poland |
43 |
| 4536 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4537 |
Apheresis |
Allogeneic |
Myeloma Multiplex |
Hematology |
2020 |
Standard Therapy |
Poland |
52 |
| 4538 |
Apheresis |
Allogeneic |
Myeloproliferative Neoplasms |
Hematology |
2020 |
Standard Therapy |
Poland |
68 |
| 4539 |
Apheresis |
Allogeneic |
Myeloproliferative Neoplasms |
Hematology |
2020 |
Standard Therapy |
Poland |
40 |
| 4540 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2020 |
Standard Therapy |
Poland |
71 |
| 4541 |
Apheresis |
Allogeneic |
No Data |
Hematology |
2020 |
Standard Therapy |
Poland |
64 |
| 4542 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
65 |
| 4543 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
58 |
| 4544 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4545 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
58 |
| 4546 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
62 |
| 4547 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
53 |
| 4548 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
57 |
| 4549 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
69 |
| 4550 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
62 |
| 4551 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
34 |
| 4552 |
Apheresis |
Autologous |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
42 |
| 4553 |
Apheresis |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
62 |
| 4554 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2020 |
Standard Therapy |
Germany |
56 |
| 4555 |
Apheresis |
Autologous |
Non-Hodgkin-Lymphoma-Relapse |
Hematology |
2020 |
Standard Therapy |
Germany |
67 |
| 4556 |
Apheresis |
Allogeneic |
Osteomyelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
68 |
| 4557 |
Apheresis |
Allogeneic |
Osteomyelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
52 |
| 4558 |
Apheresis |
Allogeneic |
Osteomyelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
64 |
| 4559 |
Apheresis |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria (Pnh) |
Hematology |
2020 |
Standard Therapy |
Poland |
57 |
| 4560 |
Apheresis |
Allogeneic |
Perforin Deficiency |
Hematology |
2020 |
Standard Therapy |
Poland |
2 |
| 4561 |
Apheresis |
Autologous |
Primary Central Nervous System Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
59 |
| 4562 |
Apheresis |
Autologous |
Primary Cerebral Diffuse Large B-Cell Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
66 |
| 4563 |
Apheresis |
Autologous |
Primary Cerebral Diffuse Large B-Cell Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
59 |
| 4564 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
63 |
| 4565 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
61 |
| 4566 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
51 |
| 4567 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
66 |
| 4568 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Poland |
61 |
| 4569 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Germany |
54 |
| 4570 |
Apheresis |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2020 |
Standard Therapy |
Germany |
58 |
| 4571 |
Apheresis |
Allogeneic |
Purine Nucleoside Phosphorylase Deficiency |
Hematology |
2020 |
Standard Therapy |
Poland |
1 |
| 4572 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
43 |
| 4573 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
76 |
| 4574 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
57 |
| 4575 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Germany |
66 |
| 4576 |
Apheresis |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2020 |
Standard Therapy |
Germany |
56 |
| 4577 |
Apheresis |
Autologous |
Secondary B-Cell Non-Hodgkin-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
73 |
| 4578 |
Apheresis |
Autologous |
Secondary Diffuse Large B-Cell Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
54 |
| 4579 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
9 |
| 4580 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
53 |
| 4581 |
Apheresis |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2020 |
Standard Therapy |
Poland |
52 |
| 4582 |
Apheresis |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2020 |
Standard Therapy |
Poland |
2 |
| 4583 |
Apheresis |
Allogeneic |
Sezary Syndrome |
Hematology |
2020 |
Standard Therapy |
Poland |
44 |
| 4584 |
Apheresis |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
14 |
| 4585 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
57 |
| 4586 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
29 |
| 4587 |
Apheresis |
Autologous |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
64 |
| 4588 |
Apheresis |
Allogeneic |
T-Cell Non-Hodgkin Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
63 |
| 4589 |
Apheresis |
Allogeneic |
T-Cell-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Poland |
29 |
| 4590 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
51 |
| 4591 |
Apheresis |
Autologous |
T-Cell-Lymphoma |
Hematology |
2020 |
Standard Therapy |
Germany |
60 |
| 4592 |
Apheresis |
Allogeneic |
T-Cell-Prolymphocytic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
55 |
| 4593 |
Apheresis |
Allogeneic |
T-Cell-Prolymphocytic Leukemia |
Hematology |
2020 |
Standard Therapy |
Poland |
74 |
| 4594 |
Apheresis |
Allogeneic |
Β – Thalassemia |
Hematology |
2020 |
Standard Therapy |
Poland |
6 |
| 4595 |
Apheresis |
Allogeneic |
Β – Thalassemia Major |
Hematology |
2020 |
Standard Therapy |
Poland |
17 |
| 4596 |
Adipose Tissue |
Autologous |
Alopecia |
Dermatology |
2020 |
Experimental Therapy |
Poland |
68,5 |
| 4597 |
Adipose Tissue |
Autologous |
Chondromalacia |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
45,9 |
| 4598 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
52,8 |
| 4599 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
63,4 |
| 4600 |
Adipose Tissue |
Autologous |
Gonarthrosis |
Orthopedy |
2020 |
Experimental Therapy |
Poland |
41,1 |